Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $3.45M in Stock for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Stock including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
Twitterhttps://creativecommons.org/publicdomain/zero/1.0/https://creativecommons.org/publicdomain/zero/1.0/
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $198.9M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Alimera Sciences | ALIM - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $27M in Sales Revenues for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported 46.69 in PE Price to Earnings for its fiscal quarter ending in June of 2021. Data for Alimera Sciences | ALIM - PE Price to Earnings including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $69.73M in Loan Capital for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Loan Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported 52.35M in Outstanding Shares in April of 2024. Data for Alimera Sciences | ALIM - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $150.38M in Assets for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $69.98M in Debt for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Debt including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $10.21M in Trade Creditors for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $3.02M in EBITDA for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Ebitda including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $-3.31M in Net Income for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Net Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $55.41M in Current Assets for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Current Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $-77K in Operating Profit for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Operating Profit including historical, tables and charts were last updated by Trading Economics this last November in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $38.79M in Equity Capital and Reserves for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Equity Capital And Reserves including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $37.08M in Trade Debtors for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Trade Debtors including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $19.84M in Current Liabilities for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $10.83M in Cash and Equivalent for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Cash And Equivalent including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences reported $-3.35M in Pre-Tax Profit for its fiscal quarter ending in June of 2024. Data for Alimera Sciences | ALIM - Pre Tax Profit including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Alimera Sciences stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.